Clinical Trial Update: Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for TQH3906 capsules in adults with moderately to severely active ulcerative colitis or Crohn's disease, with the study currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• TQH3906

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Inflammatory Bowel Diseases | Phase 1 | Status: NOT_YET_RECRUITING